{"transactions":[{"id":758690,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"Bianco James A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:18.000Z","date":"2026-05-28","kind":"gift","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents gifts to adult sons who do not share same household with reporting person."}],"balance_after":2173307,"source":{"system":"sec-edgar","filing":"0000897069-26-001285","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089706926001285/form4.xml","form_type":"4"}},{"id":943186,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"Bianco James A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (Right to Buy)","published_at":"2026-01-08T21:33:52.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":610332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a supplemental option grant to the option grant previously made in December 2025. One-third of the stock options become exercisable on the first, second, and third anniversary of January 6, 2025."}],"balance_after":610332,"derivative":{"exercise_price":0.73,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":610332},"source":{"system":"sec-edgar","filing":"0000897069-26-000111","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089706926000111/form4.xml","form_type":"4"}},{"id":964968,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"Bianco James A.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Options (Right to Buy)","published_at":"2025-12-17T11:36:45.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":3414891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the stock options become exercisable on the first, second, and third anniversary of December 12, 2025."}],"balance_after":3414891,"derivative":{"exercise_price":1.02,"expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":3414891},"source":{"system":"sec-edgar","filing":"0000897069-25-001807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089706925001807/form4.xml","form_type":"4"}},{"id":1365081,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"Bianco James A.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Options (Right to Buy)","published_at":"2024-11-14T21:48:55.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":1065990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the stock options become exercisable on the first, second, and third anniversary of November 12, 2024."}],"balance_after":1065990,"derivative":{"exercise_price":4.94,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":1065990},"source":{"system":"sec-edgar","filing":"0000897069-24-002166","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089706924002166/form4.xml","form_type":"4"}},{"id":1382901,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"Bianco James A.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Options (Right to Buy)","published_at":"2024-10-23T00:10:14.000Z","date":"2024-10-18","kind":"grant","planned":false,"acquired":true,"shares":191280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Securities issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 2, 2024 (the \"Merger Agreement\"), among the Issuer (fka \"Kintara Therapeutics, Inc.\"), Kayak Mergeco, Inc., a Delaware corporation and wholly owned subsidiary of Issuer (\"Merger Sub\"), and TuHURA Biosciences, Inc., a Delaware corporation (\"Private TuHURA\"). Under the terms of the Merger Agreement, on October 18, 2024, Merger Sub merged with and into Private TuHURA (the \"Merger\") with Private TuHURA surviving the Merger as a wholly owned subsidiary of the Issuer. Upon the closing of the Merger, securities of Private TuHURA were converted into the right to receive securities of the Issuer as set forth in the Merger Agreement. The Issuer subsequently changed its name to \"TuHURA Biosciences, Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the stock options become exercisable on the first, second and third anniversary of February 28, 2024."}],"balance_after":191280,"derivative":{"exercise_price":4.14,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":191280},"source":{"system":"sec-edgar","filing":"0000897069-24-001996","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089706924001996/form4.xml","form_type":"4"}},{"id":1382900,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"Bianco James A.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Options (Right to Buy)","published_at":"2024-10-23T00:10:14.000Z","date":"2024-10-18","kind":"grant","planned":false,"acquired":true,"shares":71560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Securities issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 2, 2024 (the \"Merger Agreement\"), among the Issuer (fka \"Kintara Therapeutics, Inc.\"), Kayak Mergeco, Inc., a Delaware corporation and wholly owned subsidiary of Issuer (\"Merger Sub\"), and TuHURA Biosciences, Inc., a Delaware corporation (\"Private TuHURA\"). Under the terms of the Merger Agreement, on October 18, 2024, Merger Sub merged with and into Private TuHURA (the \"Merger\") with Private TuHURA surviving the Merger as a wholly owned subsidiary of the Issuer. Upon the closing of the Merger, securities of Private TuHURA were converted into the right to receive securities of the Issuer as set forth in the Merger Agreement. The Issuer subsequently changed its name to \"TuHURA Biosciences, Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the stock options become exercisable on the first, second, and third anniversary of April 7, 2023."}],"balance_after":71560,"derivative":{"exercise_price":3.69,"expiration_date":"2033-04-07","underlying":"Common Stock","underlying_shares":71560},"source":{"system":"sec-edgar","filing":"0000897069-24-001996","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089706924001996/form4.xml","form_type":"4"}},{"id":1382899,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"Bianco James A.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Options (Right to Buy)","published_at":"2024-10-23T00:10:14.000Z","date":"2024-10-18","kind":"grant","planned":false,"acquired":true,"shares":357800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Securities issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 2, 2024 (the \"Merger Agreement\"), among the Issuer (fka \"Kintara Therapeutics, Inc.\"), Kayak Mergeco, Inc., a Delaware corporation and wholly owned subsidiary of Issuer (\"Merger Sub\"), and TuHURA Biosciences, Inc., a Delaware corporation (\"Private TuHURA\"). Under the terms of the Merger Agreement, on October 18, 2024, Merger Sub merged with and into Private TuHURA (the \"Merger\") with Private TuHURA surviving the Merger as a wholly owned subsidiary of the Issuer. Upon the closing of the Merger, securities of Private TuHURA were converted into the right to receive securities of the Issuer as set forth in the Merger Agreement. The Issuer subsequently changed its name to \"TuHURA Biosciences, Inc.\""}],"balance_after":357800,"derivative":{"exercise_price":3.69,"exercise_date":"2024-10-18","expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":357800},"source":{"system":"sec-edgar","filing":"0000897069-24-001996","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089706924001996/form4.xml","form_type":"4"}},{"id":1382898,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"Bianco James A.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-23T00:10:14.000Z","date":"2024-10-18","kind":"grant","planned":false,"acquired":true,"shares":2323307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Securities issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 2, 2024 (the \"Merger Agreement\"), among the Issuer (fka \"Kintara Therapeutics, Inc.\"), Kayak Mergeco, Inc., a Delaware corporation and wholly owned subsidiary of Issuer (\"Merger Sub\"), and TuHURA Biosciences, Inc., a Delaware corporation (\"Private TuHURA\"). Under the terms of the Merger Agreement, on October 18, 2024, Merger Sub merged with and into Private TuHURA (the \"Merger\") with Private TuHURA surviving the Merger as a wholly owned subsidiary of the Issuer. Upon the closing of the Merger, securities of Private TuHURA were converted into the right to receive securities of the Issuer as set forth in the Merger Agreement. The Issuer subsequently changed its name to \"TuHURA Biosciences, Inc.\""}],"balance_after":2323307,"source":{"system":"sec-edgar","filing":"0000897069-24-001996","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089706924001996/form4.xml","form_type":"4"}},{"id":4590916,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"BIANCO JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-10-03T20:39:14.000Z","date":"2016-10-02","kind":"grant","acquired":true,"shares":4539290,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4539290,"derivative":{"exercise_price":0.3743,"exercise_date":"2016-10-02","expiration_date":"2018-10-14","underlying":"Common Stock","underlying_shares":4539290},"source":{"system":"sec-edgar","filing":"0000899243-16-030608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924316030608/doc4.xml","form_type":"4"}},{"id":4590915,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":43159,"kind":"person","name":"Bianco James A.","position":1,"cik":"0001198554","reported_name":"BIANCO JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-10-03T20:39:14.000Z","date":"2016-10-02","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2000000,"derivative":{"exercise_price":1.1,"exercise_date":"2016-10-02","expiration_date":"2018-10-14","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0000899243-16-030608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924316030608/doc4.xml","form_type":"4"}}]}